Clustering data with hclust algorithm for Minimal change disease and focal segmental sclerosis in urine (Study ST000329)

Reversed phase NEGATIVE ION MODE (Analysis AN000526)
MetaboliteStructureF1F2F3
FA (20:5)ME1158390.210.292.30
PE (32:1)ME1158790.033.260.03
LPC (18:1)ME1158510.023.170.12
LPC (16:0)ME1158480.013.200.10
LPC (18:0) AME1158490.023.210.08
LPC (18:0) BME1158500.023.220.07
PC (36:4) BME1158660.102.680.44
PC (p-38:4) or PC (o-38:5)ME1158770.132.670.43
PC (34:2)ME1158580.132.550.52
LPE (16:0)ME1158530.142.590.49
PC (p-36:3) or PC (o-36:4)ME1158750.172.570.46
FA (20:4)ME1158380.022.520.65
PC (36:3) AME1158630.162.450.58
PC (38:4)ME1158690.172.480.55
PI (36:4)ME1159040.142.490.57
LPC (18:2)ME1158520.023.010.25
PC (38:5) AME1158700.092.950.23
PC (38:5) BME1158710.192.740.32
PC (36:5)ME1158670.102.790.36
PC (38:6)ME1158720.102.820.33
Ceramide (d42:1)ME1158290.392.220.56
PE (36:4)ME1158840.302.130.71
PC (38:3)ME1158680.222.170.75
Ceramide (d42:2) AME1158300.172.220.76
PC (34:3)ME1158590.202.210.74
PE (38:6)ME1158860.242.240.67
PI (34:2)ME1159020.162.310.69
PI (36:2)ME1159030.192.290.69
PC (36:1)ME1158610.302.040.78
PC (36:2)ME1158620.222.080.83
PI (38:4)ME1159050.262.040.82
PC (36:3) BME1158640.242.030.85
SM (d42:3)ME1159260.262.000.86
SM (d34:2)ME1159100.122.200.82
Ceramide (d42:2) BME1158310.162.120.85
PC (32:0)ME1158550.142.130.86
FA (22:4)ME1158400.201.960.94
FA (18:1)ME1158360.141.911.04
PC (36:4) AME1158650.111.971.01
Ceramide (d40:2)ME1158260.261.761.05
SM (d32:1)ME1159060.271.771.03
PE (34:2)ME1158810.401.720.95
SM (d36:2)ME1159120.401.671.00
Ceramide (d41:1)ME1158270.511.940.67
PC (p-36:4) or PC (o-36:5)ME1158760.421.940.76
SM (d36:1)ME1159110.421.940.76
PE (38:4)ME1158850.531.790.78
Ceramide (d40:1)ME1158250.441.830.83
PE (p-38:6) or PE (o-38:7)ME1158980.471.780.85
SM (d42:2) AME1159230.291.910.90
GlcCer (d42:2)ME1158460.381.840.88
PC (34:1)ME1158570.351.830.91
PC (40:6) AME1158730.751.820.56
PC (40:6) BME1158740.811.750.56
PE (p-38:5) or PE (o-38:6)ME1158970.551.481.01
PE (p-40:6) or PE (o-40:7)ME1158990.631.610.84
LPE (20:4)ME1158540.821.490.76
PE (p-36:2) or PE (o-36:3)ME1158930.761.290.98
PE (p-40:7) or PE (o-40:8)ME1159000.831.350.87
Ceramide (d44:1)ME1158321.370.850.79
PC (p-42:5) or PC (o-42:6)ME1158781.520.750.73
GlcCer (d41:1)ME1158440.791.141.08
GlcCer (d42:1)ME1158450.721.141.14
PE (34:1)ME1158800.611.231.17
PE (36:2)ME1158820.641.161.20
Ceramide (d36:1)ME1158230.671.121.20
FA (16:0)ME1158330.681.091.22
GlcCer (d40:1)ME1158430.771.041.17
SM (d41:1)ME1159200.761.061.17
SM (d38:0)ME1159130.770.961.24
SM (d40:1)ME1159170.770.991.22
SM (d39:1)ME1159160.591.061.32
SM (d42:0)ME1159210.681.041.26
SM (d42:1)ME1159220.701.021.26
PC (32:2)ME1158560.650.971.34
SM (d38:1)ME1159140.671.001.30
PE (40:8)ME1158880.650.741.53
PE (44:3)ME1158890.920.601.40
PE (p-34:1) or PE (o-34:2)ME1158900.930.711.30
PC (34:4)ME1158600.810.771.36
PE (36:3)ME1158830.810.781.35
GlcCer (d38:1)ME1158420.810.841.31
PE (p-34:2) or PE (o-34:3)ME1158910.790.841.32
PE (p-36:1) or PE (o-36:2)ME1158920.920.821.22
Ceramide (d33:1)ME1158190.850.941.18
PE (p-36:4) or PE (o-36:5)ME1158940.850.911.22
PE (38:7)ME1158871.120.711.13
Ceramide (d42:0)ME1158281.051.210.78
FA (18:0)ME1158350.891.061.05
PE (p-38:4) or PE (o-38:5)ME1158960.891.071.05
FA (22:6)ME1158410.951.001.05
PE (p-38:3) or PE (o-38:4)ME1158950.981.030.99
Ceramide (d34:0)ME1158201.040.891.05
GlcCer(d14:1(4E)/20:0(2OH))ME1158471.050.990.96
FA (16:1)ME1158340.511.151.33
SM (d33:1)ME1159070.291.271.42
SM (d34:0)ME1159080.391.261.34
PG (40:8)ME1159010.171.291.51
Ceramide (d34:1)ME1158210.231.131.59
Ceramide (d34:2)ME1158220.201.061.68
FA (18:2)ME1158370.051.711.28
SM (d40:2) AME1159180.361.481.19
SM (d42:2) BME1159240.391.601.07
SM (d40:2) BME1159190.361.551.13
SM (d42:2) CME1159250.331.571.15
Ceramide (d38:1)ME1158240.511.381.13
SM (d34:1)ME1159090.401.341.27
SM (d38:2)ME1159150.411.401.21

Factors:

F1Sample type:Control
F2Sample type:FSGS
F3Sample type:MCD
Data matrix
  logo